An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis

There is no FDA-approved treatment for metastatic uveal melanoma (UM) and overall outcomes are generally poor for those who develop liver metastasis. We performed a retrospective single-institution chart review on consecutive series of UM patients with liver metastasis who were treated at Thomas Jef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Seedor, Rino S., Eschelman, David J., Gonsalves, Carin F., Adamo, Robert D., Orloff, Marlana, Amjad, Anjum, Sharpe-Mills, Erin, Chervoneva, Inna, Shields, Carol L., Shields, Jerry A., Mastrangelo, Michael J., Sato, Takami
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016993/
https://ncbi.nlm.nih.gov/pubmed/31906411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010117
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados